News

April 24, 2014 — SCL Health System, a faith-based, nonprofit healthcare organization, announced an agreement to implement Stanson Health's next-generation clinical decision support (CDS) system. Stanson's CDS solutions are designed to safely reduce the cost and potential for harm from unnecessary care, by providing easy-to-use, real-time alerts and analytics to help guide physicians' decisions.

Home April 24, 2014
Home
Technology

April 24, 2014 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for its latest generation of defibrillators and heart failure devices. The newly approved devices include the Dynagen Mini and Inogen Mini ICDs (implantable cardioverter defibrillators), as well as the Dynagen X4 and Inogen X4 CRT-Ds (cardiac resynchronization therapy devices).

Home April 24, 2014
Home
News

Singulex Inc. presented new data at the American Heart Association Epidemiology and Prevention Council Conference highlighting research results using the company’s proprietary ultrasensitive Erenna Immunoassay System in the detection of cardiac troponin-I (cTnI).

Home April 24, 2014
Home
News

Allison Morgan was in pretty bad shape when the medical helicopter touched down on the rooftop helipad of the University of Alabama at Birmingham Hospital (UAB).

Home April 24, 2014
Home
News

Three weeks after delivering her first child, Amanda began to suffer from extreme fatigue, headaches, a tight chest and stomach pain. An initial diagnosis of pneumonia changed for the worse: Amanda was experiencing heart failure.

Home April 23, 2014
Home
News

Interim results from The Chocolate Bar Registry conducted in the United States demonstrate that use of the Chocolate PTA balloon achieved high rates of treatment success and limb preservation in patients with peripheral arterial disease.

Home April 23, 2014
Home
News

April 23, 2014 — Vital Images, a Toshiba Medical Systems Group company, is experiencing a significant increased demand for its VitreaView universal viewer as healthcare leaders seek opportunities to meet Stage 2 Meaningful Use requirements, connect physicians and patients to images and integrate imaging into their EMRs (electronic medical records), HIEs (health information exchanges) and EHRs (electronic health records).

Home April 23, 2014
Home
News

April 23, 2014 — The PROCEED II heart transplant U.S. Food and Drug Administration (FDA) pivotal trial results using the Organ Care System (OCS) Heart platform were announced at the International Society for Heart and Lung Transplantation (ISHLT) 34th annual meeting and scientific sessions in San Diego.

Home April 23, 2014
Home
News

April 23, 2014 — Xeltis announced it finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels.

Home April 23, 2014
Home
News

April 23, 2014 — Philips Healthcare has completed its first field study for its Minicare handheld cardiac Troponin-I (cTn-I) blood test, demonstrating the platform’s potential to produce lab-equivalent results with finger prick samples within minutes. The initial results are encouraging as Philips prepares for the Minicare cTn-I system’s clinical trial, scheduled for 2015.

Home April 23, 2014
Home
Corevalve, FDA, Edwards, TAVR, TAVI, lawsuit, injunction
Feature

The Federal Circuit Court of Appeals granted a request from Medtronic Inc. to postpone the implementation of an injunction that would have prevented the company from selling its CoreValve System in the United States. The April 21 decision means the injunction will only take effect if the appellate court determines the injunction was properly issued.

Home April 22, 2014
Home
News

Loyola University Medical Center is now offering patients the most advanced positron emission tomography/computed tomography (PET/CT) scanner on the market.

Home April 22, 2014
Home
Technology

Volcano Corp. announced U.S. Food and Drug Administration (FDA) clearance of its proprietary Instant Wave-Free Ratio (iFR) modality.

Home April 22, 2014
Home
News

April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become the clinical gold standard in the treatment of chronic heart failure (CHF). Already available in Europe, where it has enjoyed moderate use in CHF and stable angina patients, ivabradine's clinical profile could prime this agent for a potentially successful launch in the United States, where Amgen own the marketing rights to procoralan.

Home April 21, 2014
Home
News

April 21, 2014 — Cardiologists and cancer experts at the Mount Sinai Hospital in Manhattan have joined forces to establish its first cardio-oncology clinic at the Tisch Cancer Institute.

Home April 21, 2014
Home
Subscribe Now